Long-term Treatment With Sequential Molecular Targeted Therapy for Xp11.2 Translocation Renal Cell Carcinoma: A Case Report and Review of the Literature

Clin Genitourin Cancer. 2017 Jun;15(3):e503-e506. doi: 10.1016/j.clgc.2016.12.026. Epub 2016 Dec 29.
No abstract available

Keywords: Mammalian target of rapamycin inhibitor; Prognosis; Renal cell carcinoma; Sequential therapy; Tyrosine kinase inhibitor.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Age of Onset
  • Antineoplastic Agents / therapeutic use
  • Axitinib
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / genetics
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / genetics
  • Catheter Ablation
  • Child
  • Combined Modality Therapy / methods
  • Everolimus / therapeutic use
  • Fatal Outcome
  • Humans
  • Imidazoles / therapeutic use
  • Indazoles / therapeutic use
  • Indoles / therapeutic use
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / genetics
  • Male
  • Molecular Targeted Therapy / methods*
  • Niacinamide / analogs & derivatives
  • Niacinamide / therapeutic use
  • Oncogene Fusion
  • Phenylurea Compounds / therapeutic use
  • Pyrroles / therapeutic use
  • Sorafenib
  • Sunitinib
  • Translocation, Genetic
  • Young Adult

Substances

  • Antineoplastic Agents
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
  • Imidazoles
  • Indazoles
  • Indoles
  • Phenylurea Compounds
  • Pyrroles
  • TFE3 protein, human
  • Niacinamide
  • Everolimus
  • Sorafenib
  • Axitinib
  • Sunitinib